Filter by
Documents (88)
RSSShowing results 40 to 60
Conclusions and next steps – forward planning of the meetings MSP Advisory Group 20 March 2024
Launch of call for Stakeholder Co-chair MSP Advisory Group 20 March 2024
Mandate and Rules of Procedure of the MSP Advisory Group 20 March 2024
ACT EU workplan and key priorities MSP Advisory Group 20 March 2024
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 March 2024)
Highlighted
ACT EU clinical trials analytics workshop report
MSP Advisory Group Mandate and rules of procedure
This document outlines the MSP Advisory Group’s mandate and rules of procedures.
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-29 February 2024)
Draft Agenda Inaugural meeting MSP Advisory Group 20 March 2024
Highlighted
ACT EU multi-stakeholder workshop on methodology guidance report
Highlighted
Summary Gap analysis of training curriculum for clinical trial assessors
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 January 2024)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 December 2023)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 November 2023)
Highlighted
Revised CTIS transparency rules & historical trials: quick guide for users
ACT EU priority areas for possible EU-level funding
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 October 2023)
Highlighted
ACT EU multi-annual workplan 2023-2026
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 September 2023)
Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 August 2023)
